Name: Ep44: Sheila Gujrathi by The Long Run with Luke Timmerman in San Diego
Duration: 1 h 12 min
Description: Sheila Gujrathi, CEO of Gossamer Bio, immunologic drug developer

Videos aggregated by Big4Bio on/from professionals in the San Diego region

San Diego

Peyton Greenside, co-founder and CEO of BigHat Biosciences, on machine-learning guided biologic drug discovery.

Ep178: Peyton Greenside on ML-Guided Biologics Discovery

Marea Therapeutics CEO Josh Lehrer and CSO Ethan Weiss on a new angle of attack against cardiovascular disease and diabetes.

Ep179: Ethan Weiss & Josh Lehrer on a New Idea for Cardiovascular Disease & Diabetes

John Rinn, professor at the University of Colorado and co-founder of Lincswitch Therapeutics, on exploring long non-coding RNA.

Ep180: John Rinn on Discovering Drugs Based on Long Non-Coding RNA

Claire Mazumdar, CEO of Boston-based Bicara Therapeutics, on developing a bifunctional antibody for head and neck cancer.

Ep181: Claire Mazumdar on a Two-Pronged Attack Against Cancer

Andy Rachleff and Yung Lie, board chair and CEO of Damon Runyon Cancer Research Foundation, on creative ways to support science amid budget cuts.

Ep182: Andy Rachleff & Yung Lie on Creative Ways to Back Science

Sabah Oney, CEO of Philadelphia and San Francisco-based Dispatch Biotherapeutics, on engineering CAR-T cells that can kill solid tumors.

Ep183: Sabah Oney on CAR-T Cells Against Solid Tumors

Jen Adair, professor and associate director of the Horae Gene Therapy Center at the University of Massachusetts Chan Medical School, on creating more affordable and accessible cell and gene therapies.

Ep184: Jen Adair on Affordable, Accessible Gene & Cell Therapies

Dr. Lachelle Weeks is a physician-scientist at Dana-Farber Cancer Institute working on a project to predict leukemia risk based on widely available blood samples.

Ep185: Dr. Lachelle Weeks on Predicting Leukemia Risk At Scale

Bruce Levine, a CAR-T cell therapy researcher at the University of Pennsylvania, and Mags McCarthy, a country music star, discuss their new song about science and hope for cancer patients. 

Ep186: Bruce Levine & Mags McCarthy on a Song About Science and Hope

Claudio Giuliano hosts a conversation with William R. Brody, four time medical entrepreneur, former president of Johns Hopkins University and Salk Institute, one of the most respected players at the crossroad of medical research and industry

Innogest Conversations

Bill Brody and the laws of physics of medical startups

Matt is the Vice President of Business Development at TSRI, as well as Chief Operating Officer at Calibr. Listen as we talk about what constitutes commercially valuable research, why TSRI is #1 for science innovation and how to design a home jungle gym.

Show notes:

Matt’s recent Biocom Catalyst Award
http://www.scripps.edu/newsandviews/i_20171002/20171002tremblay_biocom.html?utm_source=newsviews&utm_medium=email&utm_campaign=internal20171002

Calibr Bio
http://www.calibr.org/about/institute-leadership/

TSRI-Calibr partnership
https://www.eurekalert.org/pub_releases/2016-10/sri-tac102016.php

Episode 3 - Matt Tremblay: Technology Transfer - From Bench to Bedside

Steve is the Director of Digital Medicine at the Scripps Translational Science Institute (STSI). Listen as we talk about Fitbits, perverse healthcare incentives and hiking to Mount Everest Base Camp.

Show notes:

Steve’s bio at STSI
https://www.stsiweb.org/about/faculty/steinhubl-steven/

STSI Precision Medicine Initiative
https://www.stsiweb.org/translational-research/precision-medicine-initiative/

DIGIMED 2017 conference program
https://www.stsiweb.org/event/digimed17/digimed17-program/

Nature Digital Medicine Journal
https://www.nature.com/npjdigitalmed/

Episode 4 - Steve Steinhubl: Digital Medicine

In this episode we speak with Dr. Satchin Panda a Professor at the Salk Institute about Circadian Rhythms and Timed-Eating.  Dr. Panda's  research focuses on circadian rhythm in health and disease. His discoveries are rated among the top ten breakthroughs of the year by the Science magazine, and he is considered as one of the top 50 influential scientists in the book “Brain Trust”. Research in his lab has shown the profound impact of ambient light and daily eating-fasting rhythm on the prevention and management of chronic diseases and cancer.

mycircadianclock.org
www.salk.edu

Circadian Rhythms And Time - Restricted Eating With Dr. Satchin Panda

In this episode of San Diego Health, host Susan Taylor and guests Dr. Philis-Tsimikas, an endocrinologist, and Tyeisha Smith, a mother of five who has been dealing with type 1 diabetes for almost two decades, discuss Smith's diagnosis, how she got educated about her condition and the clinical trial that changed her life: www.scripps.org/6428p

Want to learn more? Follow us @ScrippsHealth!

Facebook: www.facebook.com/scrippshealth/
Twitter: twitter.com/ScrippsHealth
YouTube: bit.ly/ScrippsYouTube
Instagram: www.instagram.com/scrippshealth/

What is diabetes? (1:01)
What's the difference between type 1 and type 2 diabetes? (1:31)
What happened to Tyeisha Smith? (2:40)
How has technology changed glucose monitoring? (4:52)
How has technology changed the delivery of insulin? (9:31)
What other new technologies are helping people who have diabetes? (10:52)
How have diabetes technologies improved Smith's life? (12:56)
What is prediabetes? (15:30)
What is Project Dulce? (20:26)
What advice would you give to people with diabetes? (24:45)

Diabetes: New Technology  Improving Diabetes Management with Dr. Philis-Tsimikas and Tyeisha Smith

Sheila Gujrathi, CEO of Gossamer Bio, immunologic drug developer

Ep44: Sheila Gujrathi

"The Long Run"

Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. 

Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

The Big4Bio Podcast shares podcasts that give insight and information about/from biotech and life science leaders and organizations within the Big4Bio regions. Check out our Playlists to hear podcasts by region.

Ep44: Sheila Gujrathi

The Long Run with Luke Timmerman

Related tracks